PHARMACY

ANI Pharmaceuticals launches 2 generics

BY Sandra Levy

ANI Pharmaceuticals has introduced 18-mg and 27-mg methylphenidate hydrochloride ER tablets.

The product is the generic of Novartis’ Ritalin.

Methylphenidate hydrochloride ER tablets are a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder in children 6 years of age and older, adolescents, and adults up to the age of 65.

The product has a market value of approximately $505 million, according to IQVIA.

ANI also announced the launch of erythromycin ethylsuccinate for oral suspension 400mg/5mL.

The product, which is indicated as a treatment for various infections, is the generic of Arbor Pharmaceuticals’ Ery-Ped.

The product had a market value of approximately $16 million, according to IQVIA.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

What area is your company focused most on in 2019?
  • Add your answer